Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-24 @ 3:53 PM
NCT ID:
NCT04452292
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed high grade neuroendocrine carcinoma that is metastatic and/or not resectable
* Adequate tissue available for genomic sequencing
* ECOG status less than or equal to 2
* Able to consent
* Patient received up to two cycles of chemotherapy prior to enrollment
* Adequate bone marrow function
* Adequate hepatic function
* Adequate renal function
Exclusion Criteria:
* Small cell carcinoma
* Psychiatric illness or social situations that limit compliance
* Pregnant and nursing women
* Patients who have completed more than two cycles of chemotherapy
* Patients with resectable cancer or eligible for curative therapy
* Patients with an actionable mutation for with guidelines recommend up-front therapy with targeted agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04452292
Study Brief:
Protocol Section:
NCT04452292